Skip to content

Emergency nursing group had better symptom scores in a COPD trial

Patients receiving emergency nursing had lower breathlessness and COPD impact scores than those receiving routine nursing, but the abstract leaves the care package and treatment duration unexplained.

By 100HP editorialAbstract-based explanation checked

Based on the published abstract. The full paper may contain additional methods, results and limitations.

The 30-second takeaway

This trial reported better post-intervention lung measurements, symptom scores and walking performance in the emergency nursing group than in the routine nursing group. Depression and anxiety questionnaire scores were also lower. The results concern the measured outcomes after care; the abstract does not establish how long the differences lasted or which nursing components mattered.

Keep in mind

Allocation procedures, intervention duration and longer-term follow-up are not described. Although the title labels this a randomized trial, abstract-only access does not allow a detailed assessment of how it was conducted.

THE NUMBERS, WITH CONTEXT

What researchers found

1.62 ± 0.66 vs 2.21 ± 0.65

Breathlessness score (mMRC)

After intervention, emergency versus routine nursing; P < .001. The assessment interval and meaning of the ± values are not specified.

Medicine (Baltimore), 2025 · Original source ↓

Several kinds of measurement

The researchers compared lung function tests, blood gas measures, symptom questionnaires and walking distance. Both groups improved on breathlessness and COPD impact scores, with lower scores in the emergency nursing group after the intervention.

What remains unclear

The abstract names emergency nursing as the intervention but gives no practical description of it. That makes it difficult to understand how the additional care differed from routine nursing or to reproduce the approach.

CHECK THE ORIGINAL

The original publication

Effects of emergency nursing interventions on the outcome of patients with chronic obstructive pulmonary disease: A randomized controlled trial.

Zhang F, Zhu P
Medicine (Baltimore) · 2025

PubMed ID
41189129
Record checked

AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.